Activist investors Macellum and Ancora pushes SpartanNash Company (SPTN) for sale review

  • March 18, 2022

POTENTIAL DEAL DETAILS

Stock SpartanNash Company Symbol SPTN
Date Announced 03/18/2022 Source Press Release
Type Company Seeking Strategic Alternatives

Activist investors Macellum Advisors and Ancora Holdings Group are nominating three directors to the board of Amazon.com Inc.-linked food distributor SpartanNash Co. (SPTN) and pushing for changes including a potential sale.

Update(s):

March 18, 2022: SpartanNash (SPTN) Addresses Director Nominations

March 18, 2022: Macellum Advisors GP, LLC and Ancora Holdings Group, LLC, who beneficially own approximately 4.5% of the outstanding common shares of SpartanNash Company (SPTN) announced their nomination of three highly qualified and independent candidates for election to the Company’s Board of Directors at the 2022 Annual Meeting of Shareholders.

April 27, 2022: United Natural Foods Inc. (UNFI)  and Oak Street Real Estate Capital are separately working on bids for U.S. food distributor SpartanNash Co (SPTN), people familiar with the matter said.

May 2, 2022: SpartanNash (SPTN) issues a statement that it has not received any offers to buy the Company, nor has it been approached directly by any strategic or financial buyer to acquire the Company.

Disclaimer: Our intent with this section of the website is to present potential deals that appear to be in the pipeline. These potential deals are ones where i) the company has indicated that it is "seeking strategic alternatives", ii) there has been an unsolicited bid for a company as mentioned in a press release by the company or iii) news about the deal has been published by a leading news organization like The Wall Street Journal, The New York Times, Bloomberg, Financial Times, The Washington Post, Reuters and The Associated Press. As best as possible we will try to avoid baseless rumors. There is a high probability that many of these potential deals may not materialize and if they do, the terms of the deal may be different from what was initially reported. Please do your own due diligence before buying or selling any securities mentioned on this website. We do not warrant the completeness or accuracy of the content or data provided.